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Article Information  ABSTRACT 
Received: 24th March 2020  Antioxidants are substances that can prevent cells from the damage caused by unstable molecules such 
as free radicals. Quercetin, a plant pigment present in many fruits, vegetables, grains, and one of the 
most beneficial antioxidants in the diet and plays an important role in helping the body and prevent free 
radical damage, which is linked to chronic diseases. The antioxidant properties of quercetin may help 
to reduce inflammation, allergy symptoms, blood pressure. A lot of studies have been done and 
experiments have been conducted both in vivo and in vitro and it has been found that in cultured cells 
many respiratory viruses were inhibited by quercetin. At a minimal inhibitory concentration of 0.03 to 
0.5μg/ml in WI-38 or Hela cells, Cytopathic effects produced by echovirus type 7,11,12,19, rhinovirus, 
poliovirus, and coxsackievirus A21 and B1 were inhibited. The plaque formed by DNA and RNA 
viruses such as Herpes Simplex Virus-1, Polio type 1, and parainfluenza types 3 were effectively 
reduced demonstrating its anti-replicative properties. This article reviews effect of quercetin on 
different types of viral infections.  
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INTRODUCTION 
Most of the Plants and it,s parts are used for their flavour, scent, 
and therapeutic uses. It has been proved that the plant extracts 
and their phytoconstituents showed various biological activities 
such as antidiabetic, antihyperlipidemic, free-radical 
scavenging, and anti-inflammatory activities. It has been studied 
that Quercetin has promising antiviral effects in inhibiting 
polymerases, proteases, reverse transcriptas, suppressing DNA 
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gyrase, and binding viral capsid protein. Quercetin (3, 3’, 4’, 5, 
7-pentahydroxyflavone) is one of the most promising 
flavonoids, and it is found in many Chinese herbs, vegetables, 
and fruits, as well as red wine. A number of experiments have 
shown that quercetin may be used as an antiproliferative, 
antioxidative, antibacterial, anticancer, and antiviral agent. It has 
been found that quercetin could protect patients in severe 
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complications associated with the pandemic influenza A (H1N1) 
virus infection [1]. Although, the details of the anti-influenza 
mechanism of Quercetin remain to be elucidated. Chlorogenic 
acid and Quercetin were derived from traditional Chinese 
medicine and tested in molecular docking against influenza A 
virus H1N1 (A/PR/8/34). It has been proved that both the 
compounds showed strong binding abilities (−10.23 and −11.05 
kcal/mol for Quercetin and chlorogenic acid, respectively) with 
Neuraminidases (NA) of this virus which was comparable with 
oseltamivir (−11.24 kcal/mol).  
 
Quercetin possesses great activity against influenza infection in 
the early stages by interacting with the HA2 subunit of influenza 
HA protein and inhibited virus-cell fusion. Quercetin and its 
derivatives may be tested in future clinical trials to enrich the 
drug arsenal against coronavirus infections due to its pleiotropic 
activities and lack of systemic toxicity. A synergistic antiviral 
action may provide an alternative or additional 
therapeutic/preventive option due to overlapping antiviral and 
immunomodulatory properties when quercetin is combined with 
vitamins C and D [2]. 
 
EFFECT OF QUERCETIN IN VIRAL INFECTIONS 
Quercetin causing a 67 percent decrease in viral RNA of the 
Dengue virus which demonstrates the property of quercetin to 
either inhibits the viral polymerases or prevents the entry of the 
virus at an IC50 of 35.7μg/mL [3]. On administering quercetin 
to athletes it was found that upper respiratory tract infections that 
were induced by stress were not observed [4]. 
 
During antiviral treatments, the first choice is to always try to 
stop the entry of the virus into the cell. It has been studied that 
administering quercetin in 0-2 hours of viral entry on MDCK 
cells of H3N2 and H1N1, an in vitro model showed decreased 
cytopathic effect post 48 hours of infection based on the ability 
to bind with hemagglutinin proteins. The effect was found 
maximum when the pretreatment was done using quercetin [5]. 
Via multiple mechanisms in BEAS-2B cells pretreatment with 
10μM quercetin in the in-vitro model inhibited Rhinovirus entry. 
It retard RV endocytosis by misdirecting EEA1 localization and 
minimized 3-4old viral load at 24 h, lowering negative-strand 
RNA and modulating interferon (IFN) and IL- 8 expressions [6]. 
As an antiviral agent quercetin can reduce HIV viral replication 
by inhibiting integrase, protease, and transcriptase enzyme [7]. 
Quercetin has been found to be inhibited Rous-associated virus-
2 (RAV-2-RT) and Maloney murine leukemia virus (MMLV-
RT) non-HIV-RT activity along with avian myeloblastosis 
reverse transcriptase (AMV-RT) by in vitro experiment [8]. Five 
hydroxyl groups on 3, 3′, 4′, 5, and 7 were assumed to be 
responsible for the antiviral effects produced by quercetin when 
compared to luteolin and baicalein where these groups were not 
found [9]. 
 
By in vitro experiments of quercetin against adenoviruses 
(ADV-3−8−11) and herpesviruses (HSV-1, 2), viral replication 
was seen at an early stage in a dose-dependent manner. At 
60mg/L 100 percent inhibition was observed [12-13]. At 10μM 
concentration of 3-methyl quercetin, 1-2 hours post-infection 
showed beneficial effects on embryonic kidney cells inoculated 
with poliovirus which demonstrates the delay in the binding of 
the heat shock elements and heat shock factor required for 
transcription of the stress genes. 
 
EFFECT OF QUERCETIN ON HCV LIFE CYCLE   
Quercetin being a natural flavonoid has shown great activity on 
various steps of the HCV life cycle in Huh-7.5 cells and primary 
human hepatocytes (PHH) infected with HCVcc. It has been 
studied that quercitin mainly decreases the viral genome 
replication along with the production of infectious HCV 
particles and the specific infectivity of the newly produced viral 
particles (by 85% and 92%, Huh7.5 and PHH respectively) [12-
13]. It has been proved that Cell culture media of Huh-7.5 cells 
infected with JFH1 have collected 72 h after treatment with 50 
μM quercetin for quantification of HCV RNA by a viral load 
assay, which provides a short overview of the assembly of 
physical viral particles regardless of whether they are infectious 
or not, and determination of infectivity titers by focus-formation 
assay, which reflects the assembly of infectious viral 
particles. It’s been observed that a decrease of the viral load by 
52.08% ± 22.6% (p = 0.016) within the medium of cells treated 
with quercetin compared to DMSO-treated cells, which can be a 
consequence of the quercetin-induced inhibition of HCV 
genome replication [13].  
 
PROTEASE INHIBITION 
Quercetin was successfully studied and found that it can inhibit 
the protease catalytic activity of the Hepatitis C virus in a dose-
dependent manner. At 1.25 mg/mL 95 percent NS3 inhibition 
was observed. At 72 hours post-infection replication of the virus 
was delayed by 70 percent of the initial rate and along with that 
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blockage in RNA production of the virus was also observed [14]. 
When quercetin is added on the cultured blood peripheral 
mononuclear cells, Interferon-gamma production from the 
helper T-cells is promoted by quercetin [15]. Lytic activity of 
NK cells, the proliferation of lymphocytes, and neutrophil 
chemotaxis were observed in mice during immunonutrition 
studies when they were administered quercetin along with 
polyphenols [16-17]. 
 
EFFECT OF QUERCETIN ON SARS COV-2 
In 1990, the possible antiviral effect of quercetin has been 
investigated on different members of the family of Corona virus; 
the first research came out indicating the possible antiviral 
effects of quercetin against bovine NCDCV and human OC43 
Coronaviruses when it was administered at 60µg/mL. With a 
cytotoxicity concentration of 50% and half maximal inhibitory 
concentration of 0.014 µg/mL in Vero cells, quercetin inhibited 
the replication of PEDV [18]. With a half-maximal inhibitory 
concentration of 73M, Pichia pastoris which contains quercetin 
prohibits 3CL-like protease. With a cytotoxicity concentration 
of 3.32mM and half-effective concentration of 83.4 µM 
coronavirus entry was prohibited by quercetin in the Vero E6 
cells. As described by Ling Yi and colleagues, “quercetin offers 
great potency in the clinical treatment of SARS”. In 2003, SARS 
coronavirus was described as a single-stranded RNA virus [19] 
consisting of 29,700 nucleotides that encodes two glycoproteins 
PP1a and PP1b by using the ribosomes for replication of the 
virus. 3C-like protease upon the synthesis of precursor 
glycoproteins causes a lytic release of replicates [20].  
 
On administration of quercetin, it binds with SARS-CoV 3CL 
protease and inhibits its proteolytic activity with an IC50 of 
42.79 ± 4.95μM [21]. In Vero E6 cells with an EC50 of 83.4μM 
Quercetin can block the entry of SARS Coronavirus producing 
minimal cytotoxicity [22]. Like SARS CoV which infects the 
type -II pneumocytes with the help of receptor angiotensin-
converting enzyme II, SARS CoV-2 which is responsible for the 
current pandemic also infects in a similar manner [23]. The 
hydroxyl group present in the quercetin binds with the same 
binding site to which the SARS CoV-2 virus binds that is the 
Gln189 site. With binding energy of 5.6 kcal/mol to 3CL pro, 
docking studies suggest it bound very well to each target. 
Quercetin binds to ACE2, Spike protein, PLpro, and RdRp 
properly which suggested Quercetin has a good potential to act 
as an antiviral agent against SARS CoV-2 [24]. 
EFFECT OF QUERCITIN IN RESPIRATORY 
INFECTION 
It has been observed that when influenza virus 
A/Udorn/317/72(H3N2) was instilled in the mice intranasally, it 
results in a significant decrease in the pulmonary concentrations 
of catalase, reduced glutathione, and superoxide dismutase [25]. 
The study also showed a decrease in vitamin E levels. All these 
effects were observed on the 5th day after viral instillation. Oral 
administration with quercetin simultaneous with viral 
instillation produced significant increases in the pulmonary 
concentrations of catalase, reduced glutathione, and superoxide 
dismutase. The study concluded that during influenza virus 
infection, there is ‘oxidative stress.’ Because quercetin restored 
the concentrations of many antioxidants, it is proposed that it 
may be useful as a drug to protect the lung from the harmful 
effects of oxygen-derived free radicals released during influenza 
virus infection [25]. 
 
EFFECT OF QUERCETIN IN COMMON COLD 
Quercitin has some promising effects on the common cold such 
as running at the nose and discharge from the nostrils because of 
its well-known antioxidant with antiviral and anti-inflammatory 
properties. 
 
TOXIC SIDE EFFECTS OF QUERCETIN 
Quercetin is reported as a mutagen based on the Ames test; at 
the same time, most in vivo creature contemplates have shown 
that quercetin might be a safe compound without any harmful 
neoplastic infection impacts. Its cost taking note of that in 1999, 
the International Agency for examination on Cancer (IARC) 
express that quercetin might not be recorded as a human 
carcinogen compound [26]. There's no distinct evidence of 
quercetin teratogenic action on embryonic development; in any 
case, in vitro examines suggest that quercetin will adversely 
affect fetal development [27].  
 
In vivo tests have shown that quercetin brought about an 
exceptionally increase in the prevalence of threatening tumors to 
the young offspring of mice lacking DNA repair [28]. An in-
vitro experiment was performed on a four-week rodent showed 
the increased ratio of liver and kidney in rodents weighing 
greater than 314 mg and 157 mg quercetin/kg body weight/day, 
severally. Besides, greater than the dose of 157 mg quercetin/kg 
body weight/day, a prooxidant efficacy was observed [29]. 
Quercetin was once in a while all around endured in human 
clinical examinations.  
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Eminently, the use of quercetin on several days at a dose of 
greater than 1,000 mg/day didn't show any impacts on natural 
liquid electrolytes, kidney, liver function, parameters of blood, 
and hematology. As of now, a high quercetin portion with 
digitalis glycoside is perceived to be the best purpose for 
poisonousness; thus, the utilization of quercetin in digoxin-
treated patients should be confined before extra information on 
appropriate dose levels is possible. Underneath bound 
circumstances, quercetin shows every revolutionary rummaging 
and supportive of oxidant movement [30].  
 
Quercetin shows mutagenicity in vitro inside the Ames test, and 
reports of mutagenicity in the 1970s have semiconductor diode 
to issues concerning its wellbeing [31]. Most in vivo tests have 
shown that quercetin isn't a substance and will be ensuring 
against Geno poisons. Dietary quercetin, round-confronted with 
the main pass digestion inside the digestive system and liver, is 
kind of completely processed, lessening the potential for 
poisonousness. At oral supplemental dosages over 1,000 mg 
each day taken for up to a couple of months, no evidence of 
poisonousness has been discovered; but, information on 
semipermanent security at high portions is missing [31].  
 
CONCLUSION 
On the administration of Quercetin, virus assembly, replication, 
and enzyme activity may be inhibited along with blockage of 
virus entry leading to a strengthened immune system causing 
early production of IFNs, interleukins, T cell maturation, and 
phagocytic activity. Not only for the SARS virus. Quercetin has 
been found very useful for almost various respiratory tract 
infections producing minimal side effects. Quercetin stops the 
viral replication by inhibiting the reverse transcriptase enzyme 
and acting on the polymerase.  
 
Broad-spectrum anti-viral properties are demonstrated by 
Quercetin which has the potential to stop viral infection at 
different levels mainly by stopping the entry of the virus, 
inhibiting the replication of the virus, and assembly of the 
proteins. They also interfere with DNA and RNA polymerases. 
As quercetin is being used as a supplement form it is found 
economical and does not shows severe side effects. Therefore, 
we suggest and recommend the use of Quercetin as a 
Prophylaxis and Treatment for COVID-19 patients and people 
suffering from upper respiratory tract infections. 
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